WALT DAVID R Insider Trading Activity

Average Profitability
16.88%
Insider Buys Quantity
45
Insider Buys Sum
$10.65M
Insider Sells Quantity
217
Insider Sells Sum
$128.95M

Insider Activity of WALT DAVID R

Biography of WALT DAVID R

No biography is available at this moment.

2025-06-13PurchaseQuanterix Corporation
QTRX
director
123,990
0.3233%
$6.14$760,803-9.08%
2025-06-12PurchaseQuanterix Corporation
QTRX
director
36,010
0.0933%
$6.23$224,166-10.99%
2025-06-09PurchaseQuanterix Corporation
QTRX
director
78,131
0.2124%
$5.34$417,220+10.28%
2025-06-06PurchaseQuanterix Corporation
QTRX
director
131,869
0.3437%
$5.43$716,576+4.19%
2024-08-20PurchaseQuanterix Corporation
QTRX
director
47,000
0.1231%
$13.29$624,630-40.92%
2022-08-10PurchaseQuanterix Corporation
QTRX
150,000
0.4084%
$8.62$1.29M+50%
2020-03-13PurchaseQuanterix Corporation
QTRX
director
54,064
0.188%
$16.66$900,912+105.36%
2020-03-13PurchaseExicure, Inc.
XCUR
director
291,066
0.3405%
$1.21$352,859+77.31%
2019-08-02PurchaseExicure, Inc.
XCUR
director
1M
1.0487%
$2.00$2M-15.25%
2017-12-11PurchaseQuanterix Corporation
QTRX
director
200,000
0.7243%
$15.00$3M-8.33%
2017-09-26PurchaseExicure, Inc.
XCUR
director
536,666
1.3163%
$3.00$1.61M
2016-04-07SaleIllumina, Inc.
ILMN
director
4,000
0.0027%
$168.90$675,596-10.77%
2016-03-15SaleIllumina, Inc.
ILMN
director
4,000
0.0027%
$149.99$599,961-0.59%
2016-02-22PurchaseDaré Bioscience, Inc.
DARE
director
1,182
0.0043%
$2.09$2,468-32.54%
2016-02-19PurchaseDaré Bioscience, Inc.
DARE
director
3,400
0.0125%
$2.08$7,058-27.67%
2016-02-18PurchaseDaré Bioscience, Inc.
DARE
director
9,000
0.033%
$2.09$18,802-25.96%
2016-02-17PurchaseDaré Bioscience, Inc.
DARE
director
8,920
0.0329%
$2.12$18,882-17.62%
2016-02-16PurchaseDaré Bioscience, Inc.
DARE
director
9,000
0.0325%
$2.00$18,028-5.17%
2016-02-12PurchaseDaré Bioscience, Inc.
DARE
director
8,622
0.0324%
$2.00$17,263+1.03%
2016-02-11PurchaseDaré Bioscience, Inc.
DARE
director
8,700
0.0324%
$2.03$17,665-1.51%
Total: 266
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.